You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / SEQUENT SCIENTIFIC

SEQUENT SCIENTIFIC
Intrinsic Value | Fundamental Analysis

Returns | 1W : 5.8% , 1M : 17.8%,1Y : 250.4%
BOM : 512529     NSE : SEQUENT    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Average
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Apr 22,2021
Price(EOD): Rs. 264.05
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 6,559.00 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
SEQUENT SCIENTIFIC 5.8% 17.8% 250.4%
SUN PHARMACEUTICAL INDUSTRIES 1.2% 11.4% 36.3%
DR REDDYS LABORATORIES 7.4% 23.5% 34.1%
DIVIS LABORATORIES -0.8% 14.8% 61.7%
CIPLA 3.3% 25.1% 62.3%
BIOCON -1.2% 2.6% 12.1%
AUROBINDO PHARMA 8.6% 23.1% 82.7%
LUPIN 1.1% 6.1% 34.7%
TORRENT PHARMACEUTICALS 0.4% 8.8% 11.6%

FUNDAMENTAL ANALYSIS OF SEQUENT SCIENTIFIC

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than SEQUENT SCIENTIFIC Premium


VALUATION OF SEQUENT SCIENTIFIC

 
Valuation Score
RatioValue
P/E
P/B
P/S
93.97
P/E Calculated based on EPS of 2.81
[ Mar2020 - Consolidated Results ]

9
P/B Calculated based on Book Value of 29.34
[ Mar2020 - Consolidated Results ]

5.41
P/S Calculated based on Revenues of 1211.49 Cr
[ TTM - Consolidated Results ]

Show Me the Stocks with Valuation better than SEQUENT SCIENTIFIC Premium


FAIR VALUE OF SEQUENT SCIENTIFIC

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
37%
71%
196%

SHARE PRICE MOMENTUM OF SEQUENT SCIENTIFIC

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.04
0.05
0
0.03
0.45
0.47
0.48
0.47
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Sep2020

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Consolidated 1 Qtr Growth 4 Qtr Growth
Revenue
Op Profit
EBIDT
Net Income
3.45%
17.09%
75.04%
85.78%
13.21%
35.61%
81.31%
64.98%
QtrlyTrend
8
Latest Qtr: Dec2020

SEQUENT SCIENTIFIC related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 3.7% 15.3% 56.9%
S&P BSE SMALL CAP 0.5% 2.5% 90.8%
S&P BSE MIDSMALLCAP 0.2% 1.7% 80%
S&P BSE 400 MIDSMALLCAP 0% 1% 81%
S&P BSE 250 SMALLCAP -0.2% 0.1% 87.8%
S&P BSE ALLCAP -0.8% -0.3% 59.7%
S&P BSE 500 -0.9% -0.4% 58.8%
NSE Indices1W1M1Y
NIFTY FREE SMALL 100 0.6% 0.8% 98.4%
NIFTY SMALLCAP250 0.3% 1% 90.9%
NIFTY MID SMALL400 -0.1% 0.9% 80.8%
NIFTY 500 -0.9% -0.4% 58.3%

FAQ [Frequently Asked Questions]


Is SEQUENT good for long term investment?

As on 22-Apr-2021, the Fundamentals of SEQUENT are Average and hence you can wait for the results to improve to invest for long term ! See Financial Performance of SEQUENT SCIENTIFIC . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is SEQUENT UnderValued or OverValued?

As on 22-Apr-2021, SEQUENT is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of SEQUENT ?

As on 22-Apr-2021, the Intrinsic Value of SEQUENT is Rs. 154.78 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 193.40
Fair Value [Median EV / Sales Model] : Rs. 154.78
Fair Value [Median Price / Sales Model] : Rs. 89.25
Median Fair Value of SEQUENT : Rs. 154.78

Is SEQUENT trading at a Premium or Discount?

As on 22-Apr-2021, SEQUENT is trading at a Premium of 71% based on the Median Intrinsic Value!

Is it right time to buy SEQUENT shares?

As on 22-Apr-2021, SEQUENT is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Financial Performance of Industry Peers of SEQUENT?

Check out Financials of Industry Peers using below links:
Financials of SUN PHARMACEUTICAL INDUSTRIES LTD
Financials of DR REDDYS LABORATORIES LTD
Financials of DIVIS LABORATORIES LTD
Financials of CIPLA LTD
Financials of BIOCON LTD
Financials of AUROBINDO PHARMA LTD
Financials of LUPIN LTD
Financials of TORRENT PHARMACEUTICALS LTD
Financials of CADILA HEALTHCARE LTD
Financials of ABBOTT INDIA LTD

What are the Frequent Comparisons with SEQUENT?

SEQUENT SCIENTIFIC LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
SEQUENT SCIENTIFIC LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
SEQUENT SCIENTIFIC LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
SEQUENT SCIENTIFIC LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
SEQUENT SCIENTIFIC LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
SEQUENT SCIENTIFIC LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
SEQUENT SCIENTIFIC LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
SEQUENT SCIENTIFIC LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
SEQUENT SCIENTIFIC LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z